These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27895721)

  • 1. Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study.
    Yoon CY; Kim YL; Han SH; Yoo TH; Sung SA; Chung WK; Chae DW; Kim YS; Ahn C; Choi KH
    Diabetol Metab Syndr; 2016; 8():75. PubMed ID: 27895721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum adiponectin is associated with anemia development in chronic kidney disease: The results from the KNOW-CKD study.
    Kim H; Yun HR; Park S; Jhee JH; Park JT; Yoo TH; Lee KB; Kim YH; Sung SA; Lee J; Kang SW; Choi KH; Ahn C; Han SH
    Cytokine; 2018 Mar; 103():1-9. PubMed ID: 29287218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
    Kim CS; Bae EH; Ma SK; Park SK; Lee JY; Chung W; Lee K; Kim YH; Oh KH; Ahn C; Kim SW;
    Clin Exp Nephrol; 2017 Aug; 21(4):608-616. PubMed ID: 27514393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease.
    Hughes JT; O'Dea K; Piera K; Barzi F; Cass A; Hoy WE; MacIsaac RJ; Maple-Brown LJ
    Obes Res Clin Pract; 2016; 10(6):659-672. PubMed ID: 26669799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease.
    Hyun YY; Lee KB; Oh KH; Ahn C; Park SK; Chae DW; Yoo TH; Cho KH; Kim YS; Hwang YH;
    Nutrition; 2017 Jan; 33():254-260. PubMed ID: 27692989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ; Lee J; Chae DW; Lee KB; Sung SA; Yoo TH; Han SH; Ahn C; Oh KH
    BMC Nephrol; 2019 Apr; 20(1):119. PubMed ID: 30943913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of serum high molecular weight (HMW) adiponectin levels in patients with coronary artery disease: associations with cardio-renal-anemia syndrome.
    Hara K; Uchida T; Takebayashi K; Sakai Y; Inoue T; Inukai T; Takayanagi K; Aso Y
    Intern Med; 2011; 50(24):2953-60. PubMed ID: 22185985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, Metabolic Abnormality, and Progression of CKD.
    Yun HR; Kim H; Park JT; Chang TI; Yoo TH; Kang SW; Choi KH; Sung S; Kim SW; Lee J; Oh KH; Ahn C; Han SH;
    Am J Kidney Dis; 2018 Sep; 72(3):400-410. PubMed ID: 29728317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.
    Yoon CY; Lee M; Kim SU; Lim H; Chang TI; Kee YK; Han SG; Han IM; Kwon YE; Park KS; Lee MJ; Park JT; Han SH; Ahn SH; Kang SW; Yoo TH
    Kidney Res Clin Pract; 2017 Mar; 36(1):48-57. PubMed ID: 28392997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.
    Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):75-80. PubMed ID: 15212647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.
    Aso Y; Suganuma R; Wakabayashi S; Hara K; Nakano T; Suetsugu M; Matsumoto S; Nakamachi T; Takebayashi K; Morita K; Inukai T
    Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people.
    Kim SM; Cho KH; Park HS
    Endocr J; 2006 Apr; 53(2):247-54. PubMed ID: 16618984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hypoadiponectinemia with metabolic syndrome in patients with polycystic ovary syndrome.
    Gulcelik NE; Aral Y; Serter R; Koc G
    J Natl Med Assoc; 2008 Jan; 100(1):64-8. PubMed ID: 18277810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin levels in renal transplant recipients with and without metabolic syndrome.
    Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST
    Transplant Proc; 2012 Apr; 44(3):676-9. PubMed ID: 22483466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-diabetic chronic kidney disease.
    Kuo IC; Wu PH; Lin HY; Niu SW; Huang JC; Hung CC; Chiu YW; Chen HC
    PLoS One; 2019; 14(7):e0220158. PubMed ID: 31323071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome.
    Winer JC; Zern TL; Taksali SE; Dziura J; Cali AM; Wollschlager M; Seyal AA; Weiss R; Burgert TS; Caprio S
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4415-23. PubMed ID: 16926246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin independently predicts metabolic syndrome in overweight Latino youth.
    Shaibi GQ; Cruz ML; Weigensberg MJ; Toledo-Corral CM; Lane CJ; Kelly LA; Davis JN; Koebnick C; Ventura EE; Roberts CK; Goran MI
    J Clin Endocrinol Metab; 2007 May; 92(5):1809-13. PubMed ID: 17311859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.